Biotech with deep-tech platform to develop truly transformative immunotherapies targeting cancer, other serious diseases
Anocca is a Swedish biotech company with a primary focus on oncology TCR-T development. We have over the past 10 years developed end-to-end capabilities for precise and highly scalable TCR-T cell therapy deployment. With over 40+ TCR assets in pipeline, Anocca’s first clinical trial will launch in Q1 2025.
Check out our rockstar contributors community and meet the people behind Sesamers!
Sesamers is the insiders advantage to professional events.
By category
By country
Stay at the forefront with our curated guide to the best upcoming Tech events.